BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 13/06/2025

FDA Classifies Cellular Analysis System for Multiplexed Antimicrobial Susceptibility Testing into Class II Special Controls

The FDA has classified the cellular analysis system for multiplexed antimicrobial susceptibility testing into Class II special controls, aiming to enhance patient access to innovative devices while ensuring safety and effectiveness.

Source: Federal Register — Food and Drug AdministrationOpen original release →